Aussie women with an aggressive form of breast cancer have been given a boost of hope this morning after the results of a worldwide drug trial showed "significant improvements" for women with high-risk, early triple-negative breast cancer. Sold as Keytruda, the drug stimulates the body's immune system to fight cancer cells. And has been called a "lifesaver" by those involved in the trial.

For more, Sunrise GP Dr Ginni Mansberg and Naama Carlin who were diagnosed with triple-negative breast cancer while she was 29 weeks pregnant join. 

See omnystudio.com/listener for privacy information.